Drug Profile


Alternative Names: 8-Chloro cyclic AMP; 8-Cl-cAMP; Adenazole™; NSC 61449

Latest Information Update: 22 Nov 2007

Price : $50

At a glance

  • Originator Terumo; Valeant Pharmaceuticals International
  • Class Adenine nucleotides; Antineoplastics; Small molecules
  • Mechanism of Action Cyclic AMP receptor agonists
  • Orphan Drug Status

    Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.

  • New Molecular Entity Yes

Highest Development Phases

  • Discontinued Cancer; Colorectal cancer

Most Recent Events

  • 16 May 2006 No development reported - Phase-I for Colorectal cancer in Russia (unspecified route)
  • 16 May 2006 No development reported - Phase-II for Colorectal cancer in USA (unspecified route)
  • 16 May 2006 No development reported - Phase-I for Cancer in United Kingdom (IV-infusion)
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at so we can help.

Back to top